Breaking Down SG&A Expenses: Alpine Immune Sciences, Inc. vs Vericel Corporation

Biotech Giants' SG&A Expenses: A Decade of Growth

__timestamp	Alpine Immune Sciences, Inc.	Vericel Corporation
Wednesday, January 1, 2014	2287709	13774000
Thursday, January 1, 2015	6844000	22479000
Friday, January 1, 2016	8586000	27388000
Sunday, January 1, 2017	6079000	35610000
Monday, January 1, 2018	8362000	49007000
Tuesday, January 1, 2019	9467000	61139000
Wednesday, January 1, 2020	10899000	68836000
Friday, January 1, 2021	14560000	97592000
Saturday, January 1, 2022	17968000	106903000
Sunday, January 1, 2023	22222000	120998000

Data in motion

A Tale of Two Biotechs: SG&A Expenses Over Time

In the competitive landscape of biotechnology, understanding financial health is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Vericel Corporation from 2014 to 2023. Over this period, Vericel's SG&A expenses surged by approximately 780%, peaking at $121 million in 2023. In contrast, Alpine Immune Sciences saw a more modest increase of around 870%, reaching $22 million in the same year.

Key Insights

2014-2018: Vericel consistently outspent Alpine, with expenses growing from $14 million to $49 million, while Alpine's expenses rose from $2 million to $8 million.
2019-2023: Both companies experienced significant growth, but Vericel's expenses grew at a faster pace, highlighting its aggressive market expansion strategy.

This financial trajectory underscores the strategic differences between these two biotech players, offering insights into their operational priorities.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation

Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation

Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation

Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.

Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.

Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.

Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends

Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.

Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation

Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights

Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.